SOURCE: StockCall

StockCall

June 21, 2011 09:10 ET

Analyst Research on Warner Chilcott plc and Vertex Pharmaceuticals Incorporated - Drug Manufacturers - Other Sector's Brain on Marketing

JOHANNESBURG, SOUTH AFRICA--(Marketwire - Jun 21, 2011) - www.stockcall.com/ offers investors comprehensive research on the Drug Manufacturers - Other industry and has completed analytical research on Warner Chilcott plc (NASDAQ: WCRX) and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX). Register with us today at www.stockcall.com/ to have free access to these researches.

Companies throughout the pharmaceutical sector are working on strategies to try and prepare themselves for the patent expirations coming during the next year. Companies have been eager to form partnerships and make acquisitions to try and bolster potentially weakening pipelines. In the fiercely competitive world of pharmaceuticals, companies in the Drug Manufacturers - Other sector look to be focusing on marketing to try and carve out a space for themselves against bigger opponents. Register now at https://stockcall.com/development/stockcall/page.php?name=register.html to have free access to our reports on the Drug Manufacturers - Other industry.

www.stockcall.com/ is an online platform where investors doing their due-diligence on the Drug Manufacturers - Other industry can have easy and free access to our analyst research and opinions on Warner Chilcott plc and Vertex Pharmaceuticals Incorporated; all investors need to do is register for a complimentary membership at https://stockcall.com/development/stockcall/page.php?name=register.html.

With its newly approved Hepatitis C medication coming to market and likely to compete directly against gargantuan Merck, Vertex Pharmaceuticals Incorporated is hoping a highly specialized sales force will help give it the edge. Investors looking for complimentary research on Vertex Pharmaceuticals Incorporated are welcome to sign up at www.stockcall.com/VRTX210611.pdf for our new report.

The laws regarding how companies are allowed to market their drugs are restrictive and can often prove difficult to adhere to. According to the FDA, unlawful promotion has more than tripled in the first year of its Bad Ad Program. Companies like Warner Chilcott Plc have received warning letters for illegal marketing. The company used an improper detail about Atelvia in a YouTube video. Investors looking for free research on Warner Chilcott plc are welcome to sign up at www.stockcall.com/WRCX210611.pdf for our new report.

Visit www.stockcall.com/ to see how companies in this industry have grown over the past years and how they are expected to perform in the future.

About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information